Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Multidisciplinary Approaches to Paraneoplastic LEMS: Insights for Healthcare Decision-Makers : Episode 5
Team- and System-Based Approaches to Managing LEMS and Ensuring Access
A panelist discusses how comprehensive care coordination between specialists, proactive adverse effect management, and innovative care models can optimize treatment outcomes for Lambert-Eaton myasthenic syndrome (LEMS) patients, particularly those with dual diagnoses like small cell lung cancer (SCLC), while ensuring both clinical effectiveness and cost-efficiency through managed care strategies.
EP: 1.LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection
EP: 2.Strategies to Alleviate the Clinical and Economic Burden of LEMS
EP: 3.The Clinical and Economic Impact of LEMS in SCLC Care
EP: 4.Using Technology for Early Detection of LEMS
Now Viewing
EP: 5.Team- and System-Based Approaches to Managing LEMS and Ensuring Access
EP: 6.The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care
EP: 7.Managed Care Partnerships and Continuity of Care
Video content above is prompted by the following:
- How can health care teams proactively manage adverse effects associated with treatments like amifampridine?
- How can managed care organizations facilitate timely access to LEMS therapies while ensuring cost-effectiveness?
- What strategies can improve communication and coordination between oncologists, neurologists, and pharmacists in managing dual-diagnosis patients?
- What innovative care models have shown promise in improving outcomes for patients with dual diagnoses like SCLC and LEMS?
Related Videos
Related Content
Understanding TB Symptoms, Spread, Treatment Amid Kansas City Outbreak
February 13th 2025Article
In part 2 of this interview, Michael A. Bernstein, MD, highlights the need for prolonged antibiotics and strong public health measures to combat tuberculosis (TB) at both the individual and population levels.
Read More
